PLACEHOLDER: Free shipping over $XX — confirm threshold

Topical cosmetics and devices only — not for injection

Cellular Sequence

Peptide Encyclopaedia

Approved medicineApproved medicine

Melatonin

Also known as N-acetyl-5-methoxytryptamine.

Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.

At-a-glance profile

Classification
Indoleamine hormone (not a peptide)
Approval status
Approved medicine
Research status
Labelled indications are defined in product information.
Molecular formula
Insufficient reliable evidence identified.
Molecular weight
Insufficient reliable evidence identified.
Sequence
Small tryptophan metabolite; listed on peptide price sheets anyway.
Primary biological target
Insufficient reliable evidence identified.
Half-life
Insufficient reliable evidence identified.
Routes investigated
Insufficient reliable evidence identified.
Human evidence level
A — Approved clinical use / strong human evidence

What is it?

A circadian hormone available as licensed or listed oral products in some markets. Injectable ‘melatonin 10 mg vials’ are not those products and are not sold here.

Mechanism of action

MT1/MT2 receptor signalling and circadian phase-shifting.

Sleepiness, prolactin and temperature effects.

What is it being studied for?

  • Jet lag / insomnia in specific licensed presentations

Investigational findings are not proven clinical benefits unless an authority has labelled that indication.

Evidence level

Overall human evidence grade: A · Approved clinical use / strong human evidence

Human research

Oral melatonin has a mixed evidence base; injectable research stock is unjustified.

Preclinical research

Animal, cell and in-vitro findings are listed separately from human effects.

Pineal hormone biology.

Doses reported in published research

This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.

Doses reported in human studies

Insufficient reliable evidence identified.

Preclinical / animal study dosing

Insufficient reliable evidence identified.

Pharmacokinetics

Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.

Safety

Next-day sedation, vivid dreams; injection adds infection risk.

Unknowns. Absence of a published harm signal is not evidence of safety.

Contraindications. Follow labelled oral products; do not inject research melatonin.

Regulatory status

Oral products may be listed/registered; injectable research melatonin is unapproved.

Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.

Citations

  1. [1] Encyclopaedia note

    Encyclopaedia note

For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.

Last reviewed 2026-09-13. Research areas: Cognitive, Healthy Ageing · Compare peptides